← Back to Search

Behavioral Intervention

COACH-Cog Intervention for Dementia (COACH-Cog Trial)

N/A
Waitlist Available
Led By Allison Magnuson
Research Sponsored by University of Rochester
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter
Awards & highlights

COACH-Cog Trial Summary

This trial aims to test a new intervention called COACH-Cog for older adults with Alzheimer's disease and related dementias who are also dealing with cancer. The researchers believe that COACH-Cog

Who is the study for?
This trial is for older adults with Alzheimer's Disease or related dementias (ADRD) who also have to make decisions about cancer treatment. They need a care partner involved in the decision-making process. Specific eligibility details are not provided, but typically participants must meet certain health and cognitive criteria.Check my eligibility
What is being tested?
The study tests COACH-Cog, a communication aid designed to help patients with ADRD and their care partners make informed decisions about cancer treatments. The goal is to support autonomy and ensure that treatment choices align with the patient's values and preferences.See study design
What are the potential side effects?
Since COACH-Cog is a communication intervention rather than a medical treatment, it does not have physical side effects like drugs do. However, its impact on emotional well-being and decision-making processes will be closely monitored.

COACH-Cog Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4-weeks post-oncology clinical encounter and 3-months post-oncology clinical encounter for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Care Partner: Health Care Climate Questionnaire (HCCQ)
Secondary outcome measures
Care Partner PROMIS Depression
Care partner PROMIS Anxiety
Care partner: Decision Regret Scale
+5 more
Other outcome measures
Patient Decision Regret Scale
Patient: Health Care Climate Questionnaire (HCCQ)
Patient: Health Care Climate Questionnaire - Age (HCCQ-Age)
+2 more

COACH-Cog Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: COACH-Cog InterventionExperimental Treatment1 Intervention
Oncology clinician intervention components: 1) a brief training video, 2) For each patient/care partner dyad that is subsequently enrolled onto the study that the clinician cares for, the oncology clinician will receive the results of the patient's GA with targeted management recommendations for identified GA domain impairments. Patient/Care partner dyad intervention components: 1) Communication coaching session; 2) Patient GA results with management recommendations to consider discussing with the oncology team will be provided to care partners and patients.
Group II: Usual CareActive Control1 Intervention
Usual Care

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH
1,668 Previous Clinical Trials
28,004,759 Total Patients Enrolled
265 Trials studying Dementia
23,623,106 Patients Enrolled for Dementia
University of RochesterLead Sponsor
836 Previous Clinical Trials
517,863 Total Patients Enrolled
5 Trials studying Dementia
933 Patients Enrolled for Dementia
Allison MagnusonPrincipal InvestigatorUniversity of Rochester
2 Previous Clinical Trials
39 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for participants in this clinical trial?

"The information from clinicaltrials.gov shows that this particular study is no longer accepting new participants. It was initially listed on 3/15/2024 and the latest update was made on 3/8/2024. While this trial has reached its recruitment goal, it's worth noting that there are currently 1298 other trials actively seeking eligible candidates."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision
Allison Magnuson 2024. "Enhancing Triadic Communication About Cognition for Older Adults With Alzheimer's Disease or Related Dementias Facing a Cancer Management Decision". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06313853.
~203 spots leftby Mar 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top